CA
NZ
UK
AU
IND
US
The transaction generated gross proceeds of approximately $2.5 million, reflecting the total cash inflow before any deductions. After accounting forUnderwritingcommissions, legal fees, filing expenses, and other customary costs, the net proceeds settled at roughly $2.1 million. This differential illustrates the typical expense ratio associated …
Syndax Pharmaceuticals Inc. (NASDAQ: SNDX) announced a remarkable revenue increase of 222.7% for its latest quarter, with total sales hitting $252.25 million. However, despite this impressive growth, SNDX shares fell 0.5% to $18.99 on the news. Investors are absorbing a mixed performance, as the …
RxSight Inc. (NASDAQ: RXST), an ophthalmic medical device company with a market capitalisation of $273 million, reported second quarter revenues of $33.7 million on August 5, 2026. This figure marks a 19% decline from the $41.5 million recorded in the same period last year, …
National Vision Holdings has made a significant move in its financial outlook, increasing the full-year adjusted operating income to between $119 million and $139 million. This strategic decision indicates management's confidence in profitability improvements driven by a focus on higher-value customer segments, despite expectations …
Nektar Therapeutics (NASDAQ: NKTR) reported financial results for the second quarter of 2026, showing a loss during the period. Despite facing challenges, the company managed to exceed expectations with anEarnings Per Share(EPS) figure that surpassed forecasts by $0.74. This performance may suggest operational improvements …
A new survey highlights a concerning trend among school-based therapists, where 71% have identified rising caseloads over the past two years, with a significant 24% indicating severe increases. This escalation affects the delivery of federally mandated services, putting at risk the academic and emotional …
The recentEarnings Callfor Valneva SE brings to light a pressing issue that has become increasingly visible within the company: the operational loss for the first half of 2026 has expanded, although the precise magnitude remains undisclosed. Management, however, emphasized an unwavering commitment to advancing …
Invivyd posted second‑quarter net product revenue of $14.3 million, representing a 21% jump from the $11.8 million recorded in the comparable period a year earlier. The lift in sales is driven primarily by sustained and strongDemandfor its PEMGARDA antibody, which has continued to attract …
IRhythm Holdings, Inc. (NASDAQ: IRTC) has made a significant governance change with Brian Yoor stepping down from its board of directors. This change comes as part of an adjustment in the company’s leadership structure, with implications for its future strategic direction. It underscores an …
KORU Medical Systems Inc. (NASDAQ: KRMD), a medical technology company with a marketCapitalizationof approximately $157 million, reported a significant Q2 revenue increase. The company generated $12 million for the quarter ending June 30, 2026, which represents an 18% growth compared to the same period …
Please wait processing your request...